Table Of Content

Index to Volume 38 PAGE NUMBERS OF ISSUES January February August March 185-296 September 809-888 Is (1) ea re eee 297-400 October 889-992 993-1104 1105-1208 Page numbers preceded by S indicate articles Acute lymphoblastic leukemia pathophysiology of, 420 in the Supplement, “Proceedings from The adult, Hoelzer regimen for, 436 pharmacotherapy for, 420 Bar Code Administration Conference, The remission induction, PVDA regimen for, screening for, 422 ALARIS Center for Medication Safety and 544 dara. See Imiquimod Clinical Improvement.” Acute myelogenous leukemia durazyme. See Laronidase consolidation or relapse therapy in, high- efacept (Amevive), 68, 164, 264, 367, 478, A dose cytarabine (HIDAC) for, 118 583 Abacavir (Ziagen). See also Zidovudine, induction therapy of, fludarabine, fuzosin (UroXatral), 66, 162, 262, 371, lamivudine, abacavir cytarabine, and filgrastim (FLAG) regi- 480, 585, 590, 685, 688, 777, 865, 961, dosage adjustment in liver failure, 1187 men for, 320 1068 dosage regimens for, 1156 relapsed or refractory, mitoxantrone, inia. See Nitazoxamide standardized order form for, 1187 etoposide, and cytarabine (MEC) regi- kaban-AQ. See Vinblastine warning related to, 269, 971 men for, 218 keran. See Melphalan Abarelix (Plenaxis), 785, 871, 967, 1073 remission induction, high-dose cytarabine legra-D. See Fexofenadine 1171 (HIDAC) plus daunorubicin for, 20 lergy, documentation, for Computerized Abbreviations, acronyms, and symbols Adalimumab (Humira), 70, 158, 257, 367 Prescriber Order Entry, 386 computerized physician order entry and, 474, 590, 688, 786, 872, 967, 1171 oxi. See Palonosetron 173 review of, 568 pha-I proteinase inhibitor (Aralast), 257, hazardous, 1004 Adderall XR. See Dextroamphetamine and 367, 478, 583 Latin, 285, 626 amphetamine teplase and medication errors, 17 Addvantage System, for IV antibiotics, 605 for catheter occlusion, 95 626, 728 Adefovir dipivoxil (Hepsera), 62, 159 for pleural effusion (parapneumonic), 1024 standardization of, 172 review of, 144 tretamine (Hexalen), exposure to, potential unacceptable, 598, 601, 626, 881, 977, Adriamycin. See Doxorubicin complications of, for caregivers, 1098 978 Adrucil. See 5-Fluorouracil Ambien. See Zolpidem vaccine, CDC-recommended, 726 Advair. See Fluticasone/salmeterol Ambulatory care, 93 Abilify. See Aripiprazole Adverse drug-related events (ADRs). See also adverse drug-related events in, 317, 416 Abilitat. See Aripiprazole Medication errors American Society of Health-System Acamprosate (Campral), 68, 70, 164, 166, in ambulatory setting, 317, 416 Pharmacists (ASHP), advocacy for bar code 265, 376, 481, 590, 688, 786, 872, 967 ; in elderly after hospital discharge, 919 medication administration, $9 1073, 1171 in ambulatory setting, 416 Amevive. See Ale facept Acarbose (Precose), warning related to, 269 with first dose, monitoring for, 605 Amifostine (Ethyol), warning related to, 9 va. Acetaminophen (Tylenol) impending, detection of, 818 Amiloride (Midamor), warning related to, aspirin, caffeine (Excedrin Migraine), outside hospital, 317, 416 874 warning related to, 1078 reduction of, bar code medication \ miloride/hydrochlorothiazide (Moduretic), dexbrompheniramine maleate, and administration and, $5, $11 warning related to, 874 pseudoephedrine sulfate extended- reference on, 801 Amiodarone (Cordarone), warning related to, release tablet (Drixoral Cold & Flu reports on, from Archives of Internal 595, 972, 1078 Extended Release, Drixoral Allergy Medicine, 633 Amlodipine/atorvastatin, 785, 872, 967, Sinus Extended Release), warning relat- with warfarin, 36 1074, 1171 ed to, 971 Aerospan. See Flunisolide Amoxicillin, crystalluria with, acute renal warning related to, 1078 AF0150 (Imavist), 66, 162, 262, 371, 480, failure caused by, 732 Acetylcysteine, for prevention of contrast 585, 685, 782, 1070, 1168 Amoxicillin/clavulanate potassium media nephropathy, 122 Agalsidase alfa (Replagal), 69, 165, 265, 372, (Augmentin SR, Augmentin XR), 64 Achilles tendon rupture, levofloxacin and, 482, 688, 785, 870, 966, 1073, 1170 Amphotericin B, liquid products, and risk 1008 Agalsidase beta (Fabrazyme), 69, 165, 264, factors for aspergillosis, 232 Acitretin (Soriatane), warning related to, 693, 372, 481, 589, 681, 778, 862 Amprenavir (Agenerase) 972 Agenerase. See Amprenavir dosage adjustment in liver failure, 118 Acquired immunodeficiency syndrome Agrylin. See Anagrelide standardized order form for, 1187 (AIDS). See HIV-infected (AIDS) patients Alarms, configurable, 882 Amprenavir/ritonavir, standardized order Acronyms. See Abbreviations, acronyms, and Albuterol, 1073, 1171 form for, 1187 symbols Alcohol withdrawal (syndrome) Anagrelide (Agrylin), hypersensitivity pneu- Actos. See Pioglitazone assessment in, 422 monitis with, 1007 Acute coronary syndrome, low molecular baclofen for, 552 Anal fissures, topical diltiazem for, 802 weight heparin with antiXa activity in, 206 diagnosis of, 422 Anastrozole (Arimidex), 65 Hospital Pharmacy 1193 index to Volume 38 warning related to, 269 Artesunate, 68, 164, 264, 372, 481, 589, Avandamet. See Rosiglitazone/metformin se Ancobon. See Flucytosine 686, 784, 870, 966, 1072, 1170 Avandia. See Rosiglitazone \nemia \simia. See Paroxetine mesylate Avapro. See Irbesartan in critical illness, 291 Ask the Joint Commission Avastin. See Bevacizumab epoetin alfa for, 1009 brand/generic drug labeling, 603 Avelox. See Moxifloxacin erythropoietin for, 291 cardiac stents, 76 Avodart. See Dutasteride hemolytic, levofloxacin-induced, 1007 concentrated KCl, 880 Avonex. See Interferon-beta-1a with proton-pump inhibitor, 112 configurable alarms, 882 Azelaic acid (Finacea), 261, 370, 479 transfusion therapy for, 291 crash cart locks, 79 Anergy skin testing, 802 DEA registration of physicians, 78 Angioedema, valsartan-induced, 909 double-check procedures, 606 Baclofen (Lioresal), for alcohol withdrawal, Angiotensin II receptor blockers, 2004 draft standards on medication use, 552 hepatotoxicity of, 417 605 Bar code medication administration Anidulafungin, 785, 872, 967, 1074, 1171 expiration dating of investigational drugs, acceptance and adoption of, $2, $3, $11, Antacids, and fluoroquinolone absorption, 881 S20 294 homeopathics/herbals on the MAR, 601 ASHP's approach to advocating for, $9 Antiandrogens, pneumonitis with, 1006 informed consent for drugs, 80 benefits of, $11, $22 Bet Antibiotics insulin as floor stock, 81 business case for, $31 Bev intravenous, Addvantage System for, 605 medication management standards for communication and administrative support Bex unintended discontinuation of, 727 2004, 82, 882, 1175 for, S20 Anticoagulation therapy. See also monitoring room temperature, 81 economics of, $11, $31 Phytonadione National Patient Safety Goals, 170, 604, equipment for, $20 Be x warfarin for, bleeding complications with, O77 human factors in, $16 36 new medication use standards for 2004, 82 implementation of, $20 Antidepressants nursing identification of patients’ own issues in, $24, $28 sleepwalking with, 633 medications, 81 and improved safety, $5 withdrawal, shock-like sensations with, ophthalmic drugs as floor stock, 80 and medication error reduction, 10 631 patient identifiers on label, 170, 881 study of, $22 Bin Antihypertensive and Lipid-Lowering pharmacist review of dialysis orders, 79 nursing and, $14, $16, $22, $30 Bio Treatment to Prevent Heart Attack Trial pharmacist review of "orderless" drugs, 81 ongoing support for, $20 (ALLHAT), 533 pharmacist review of orders, 602 as patient safety measurement tool, $30 Antineoplastics PRN orders, 878 perils and pearls, $21 preparation by conventional IV versus range orders, 878 proposed FDA rule for, 10, $7, S11 closed system, and environmental resume orders, 598 staff buy-in and, $20 contamination, 135 sample drug documentation, 80 summit meeting on, 817 workplace contamination with sliding scale insulin order on MAR, 881 training and support for, S20 preparation method and, 135 storage of concentrated electrolytes, 603 UPS system as model for, $18 sources of, 135 transfer order requirements, 79 Basic Bibliographies Antipsychotics unacceptable abbreviations, 598, 881 ambulatory care, 93 atypical, 885 volunteers used for drug delivery, 78 anemia: critical iliness, 291 priapism with, 319, 418 Asparaginase. See also PVDA (prednisone, attention-deficit/hyperactivity disorder, typical, 886 vincristine, daunorubicin, and asparagi- 1093 weight gain with, topiramate for, 328 nase) regimen t benign prostatic hyperplasia, 94 Antiretroviral therapy Asparaginase (Elspar), exposure to, potential bioterrorism, 613 dose reductions in end organ disease, 1187 complications of, for caregivers, 1098 cachexia: cancer-related, 389 plus metformin, fatal lactic acidosis Aspergillosis, risk factors for, liquid ampho- catheter occlusion: alteplase, 95 caused by, 909 tericin B products and, 232 catheter occlusion: other therapies, 506 Blc standardized order form for, 1187 Atacand. See Candesartan cilexetil catheter occlusion: reteplase, 614 Bo \pomorphine (SQ), 785, 872, 967, 1074, Atazanavir (Reyataz), 165, 265, 376, 482, compounding issues, 804 1171 590, 686, 688, 777, 865, 961, 1068 counseling, 292 \pomorphine (Uprima), 68, 164, 264, 372, warning related to, 972 drug-induced psychiatric symptoms, 803 Bo 481, 589, 686, 784, 870, 966, 1072, 1170 Atomoxetine (Strattera), 61, 159, 258, 368 drug shortages, 803 \prepitant (Emend), 376, 482, 582, 682, 778 Atorvastatin (Lipitor), 64, 161, 261 ephedra, 1094 Bo review of, 763 multiorgan failure due to, 17 fall risk assessment and prevention, 390 AquaMephyton. See Phytonadione, injection AtroPen. See Atropine fluoroquinolone absorption interactions, ARA-C. See Cytarabine Atropine (AtroPen), 781, 866, 962 292, 506 Br: Aralast. See Alpha-I proteinase inhibitor warning related to, 1174 hepatic artery infusion, 392 Br Arava. See Leflunomide Attention-deficit/hyperactivity disorder, 1093 hepatitis C, 180 Archives of Internal Medicine, ADR-related Augmentin SR. See Amoxicillin/clavulanate index of, 1163 reports from, 633 potassium journal clubs, 709 Bu Arcoxia. See Etoricoxib Augmentin XR. See Amoxicillin/clavulanate managed care, 710 Bu Aricept. See Donepezil potassium Medicaid, 509 Ariflo. See Cilomilast AutoDose Infusion System bags, osteogenesis imperfecta, 181 Arimidex. See Anastrozole imipenem-cilastatin sodium in, stability of, personality disorders, 1184 Aripiprazole (Abilify, Abilitat), 61, 159, 257, 130 pharmaceutical care, 990, 1096 368, 376, 482, 590, 688, 786, 871, 872, Automation, for medication and supply pharmacy ethics, 711 967, 1069, 1074, 1171 delivery pharmacy technicians, 1185 review of, 247 and pharmacist review of orders, 602 physical assessment, 183 Arixtra. See Fondaparinux sodium stocking errors in, look-alike names and polycystic ovary syndrome, 991 Artane. See Trihexyphenidy] packages and, 312 psychotic disorders, 885 1194 Volume 38, December 2003 Index to Volume 38 sexual dysfunction and psychotropic C satety of, 33 medications, 991 Cachexia, cancer-related, 389 armustine (BiCNU, Gliadel), exposure to, sexually transmitted diseases, 804 Caftergot. See Ergotamine tartrate and caf- potential complications of, for caregivers, stroke, 886 feine 1098 Beclomethasone dipropionate (Beconase Calcitonin (Fortical), 482, 590, 688, 786. arvedilol (Coreg), 264, 372, 481, 589, 686, Nasal), warning related to, 595 872, 967, 1074, 1171 870, 966, 1072, 1170 Beconase Nasal. See Beclomethasone dipropi- Calcium, and fluoroquinolone absorption, asodex. See Bicalutamide onate 508 atheter occlusion Benicar HCT. See Olmesartan Calcium gluconate, storage of, 604 alteplase for, 95 medoxomil/hydrochlorothiazide Campral. See Acamprosate reteplase for, 614 Benign prostatic hyperplasia, 94 Camptosar. See Irinotecan therapies, 506 Benzodiazepines, for alcohol withdrawal Cancer eeNU. See Lomustine (syndrome), 420, 423 bone metastases, prevention of, 1148 amet epime (Maxipime , warning related to, 17-Beta-estradiol (Estrasorb), 70, 166, 265, cachexia related to, 389 97) 376, 482, 590, 688, 786, 871, 967, 1073, testicular. See Testicular cancer efotan. See Cefotetan 1163 Cancer Chemotherapy Updates erotetan Cefotan), warning related to, 1174 Betaseron. See Interferon-beta-1b bleomycin, etoposide, and cisplatin (BEP) elebrex. See Celecoxib Bevacizumab (Avastin), 1171 regimen for testicular cancer, 638 alcdmaaaeta se: elecoxib (Celebrex Bexarotene (Targretin), warning related to; bortezomib, 733 adverse drug events with, 1122 972 cisplatin, vinblastine, and bleomycin (PVB) and blood pressure, 556 Bextra. See Valdecoxib regimen for testicular cancer, 822 hepatitis with, 117 Bexxar. See lodine-131 tositumomab; Tositu- cisplatin and ifosfamide with vinblastine elexa. See Citalopram momab or etoposide (VIP) regimen for testicular ellCept. See Mycophenolate mofetil Bicalutamide (Casodex), 69, 70, 165, 166, cancer, 1016 ertican. See Everolimus 265, 376, 482 CVP (cyclophosphamide, vincristine, and erubidine. See Daunorubicin pneumonitis with, 1006 prednisone) regimen for chronic lym- etirizine Zyrtec), 65, 161, 261 BiCNU. See Carmustine phocytic leukemia and small lymphocyt etuximab (Erbitux), 70, 166, 265, 376, 482, Binge eating disorder, topiramate for, 1133 ic lymphomas, 1126 591, 689, 786, 872, 968, 1074, 1171 Bioterrorism, 613 etoposide and cisplatin (EP) regimen for hemotherapy Bismuth subcitrate, metronidazole, tetracy- testicular cancer, 921 cytotoxic agents for, exposure to, potential cline (Helicide), 68, 164 fludarabine, cytarabine, and filgrastim complications of, for caregivers, 1097 Bisoprolol fumarate (Zebeta), warning related (FLAG) regimen for induction therapy medication errors in, 712 to, 874 of acute myelogenous leukemia or safety standards for, 1029 Bisoprolol fumarate/hydrochlorothiazide myelodysplastic syndrome, 320 hildren (Ziac), 876 gefitinib, 734 dosage and administration for, specification Bleeding high-dose cytarabine for consolidation or in orders, 173 low molecular weight heparin with antiXa relapse therapy of acute myelogenous drips and infusions for, drug concentrations activity and, 206 leukemia, 118 for, 979 with warfarin, 36 high-dose cytarabine (HIDAC) plus gastroesophageal reflux in, 212 Blenoxane. See Bleomycin daunorubicin for remission induction of male, with delayed puberty, letrozole for, Bleomycin (Blenoxane). See also Cisplatin, acute myelogenous leukemia, 20 9090 vinblastine, and bleomycin (PVB) regimen Hoelzer regimen for therapy of adult acute neonatal abstinence syndrome in, treatment etoposide, and cisplatin (BEP) regimen, lymphoblastic leukemia, 436 of, 282 for testicular cancer, 638 mitoxantrone, etoposide, and cytarabine ophthalmic drug overdose in, due to exposure to, potential complications of, for (MEC) regimen for relapsed or systemic absorption, 201 caregivers, 1098 refractory acute myelogenous leukemia, pulmonary hypertension in, sildenafil for, Blood pressure, COX-2 inhibitors and, 556 218 646 Body weight. See also Weight PVDA regimen for remission induction of topical isopropyl alcohol and hemorrhagic actual, or lean body weight, in dosage acute lymphoblastic leukemia, 544 gastritis in, 17 calculation, 820 Candesartan cilexetil (Atacand) hlorambucil (Leukeran), exposure to, poten- Bone metastases, prevention of, zoledronic hepatotoxicity of, 417 tial complications of, for caregivers, 1098 acid vs pamidronate for, 1148 warning related to, 74, 876 C hlorhexidine (PerioChip), warning related Bortezomib (Velcade), 265, 376, 482, 590, Capecitabine (Xeloda) to, 595 681, 778, 865, 961 exposure to, potential complications of, for ~ hlorzoxazone, pharmacokinetics of, 338 review of, 733 caregivers, 1098 holesterol absorption inhibitor. See Bradycardia, thalidomide-induced, 910 warning related to, 972 Ezetimibe Bronchitis, chronic, acute exacerbations; Carac. See 5-Fluorouracil ai horiogonadotropin alfa (Ovidrel), 1167 gemifloxacin mesylate for, 854 Carbidopa, levodopa, entacapone (Stalevo), hronic lymphocytic leukemia, CVP Broselow system, 1177 781, 866, 962 (cyclophosphamide, vincristine, and pred- Buprenorphine (Subutex), 62, 159, 258 Carboplatin (Paraplatin), exposure to, nisone) regimen for, 1 126 Buprenorphine/naloxone (Suboxone), 62, potential complications of, for care- ialis. See Tadalafil 159, 258 givers, 1098 idecin. See Daptomycin Bupropion (Wellbutrin XL, Zyban), 869, Cardiac stents, 76 ‘gstiuinnl ilomilast (Ariflo), 871, 967, 968, 1073, 965, 1069, 1167 Cardioplegia solutions, 979 1170, 1171 warning related to, 876 Cardiopulmonary resuscitation, pharmacists ipro. See Ciprofloxacin Busulfan (Busulfex, Myleran) role in, 40 aat.e iprodex. See Ciprofloxacin and dexametha- exposure to, potential complications of, for Carimune NEF. See Immune globulin (human) sone caregivers, 1098 Carisoprodol (Soma) iprofloxacin (Cipro, Cipro XR), 70, 161, warning related to, 595 abuse potential of, 227 261, 370, 1069, 1167 ID Busulfex. See Busulfan efficacy of, 33 C iprofloxacin and dexamethasone (Ciprodex), 962, 1069 1195 Hospital Pharmacy Index to Volume 38 Cipro XR. See Ciprofloxacin 676 acute myelogenous leukemia, 118 Cisplatin (Platinol, Platinol-AQ). See also on influenza vaccine (live, intranasal), 955 plus daunorubicin, for remission induction Bleomycin, etoposide, and cisplatin (BEP on omalizumab, 1063 in acute myelogenous leukemia, 20 regimen; Etoposide and cisplatin (EP) on rasburicase, 56 Cytosar U. See Cytarabine on teriparatide, 471 Cytotoxic agents, exposure to, potential regimen exposure to, potential complications of, for ontrast media nephropathy, prevention of, complications of, for caregivers, 1097 caregivers, 1098 acetylcysteine for, 122 Cytoxan. See Cyclophosphamide warning related to, 489 opegus. See Ribavirin ai isplatin, vinblastine, and bleomycin (PVB) ordarone. See Amiodarone D regimen, for testicular cancer, , 822 oreg. See Carvedilol Dacarbazine (DTIC-Dome), exposure to, Cisplatin and ifosfamide with vinblastine or osmegan. See Dactinomycin potential complications of, for caregivers, etoposide (VIP) regimen, for testicular ‘osts and cost analysis. See Economics 1099 cancer, 1016 ounseling, 292 Daclizumab (Zenapex), warning related to, Cisplatin/epinephrine (IntraDose), in bovine ‘ounterfeiting, medication, 194, 724 973 collagen gel, 801 overa-HS. See Verapamil Dactinomycin (Cosmegan) Citalopram (Celexa), warning related to, 489 oviracil. See Emtricitabine exposure to, potential complications of, for Cladribine (Leustatin), exposure to, potential DMRROAAX D-R2D ADiAnhDiLbHit ors caregivers, 1099 complications of, for caregivers, 1098 adverse drug events with, 1122 warning related to, 973 rn laritin. See Loratadine and blood pressure, 556 Dalteparin, in total knee replacement, costs Clavulanic acid, immediate hypersensitivity ozaar. See Losartan and outcomes with, 833 to, 1124 ~ rash cart, lock for, 79 Daptomycin (Cidecin, Cubicin), 165, 265, Clinical interventions, by dispensing pharma- reatine kinase (CK), elevation of, tenofovir 379, 482, 591, 689, 786, 872, 968, 1066, cists, 1047 and, 18 1163 documentation of, 346, 1141 restor. See Rosuvastatin calcium Darifenacin (Enablex), 785, 872, 968, 1074 PDAs and, 497, 1047, 1180 ~~ ritical Care Therapeutics 1168 aC linical studies, pharmacist support for, 140 anemia and epoetin alfa, 1009 Data mining, for health system pharmacist, Clobetasol propionate (Olux), 66, 70, 162, glycemic control in, 702 845 166, 262, 265, 371, 376, 480, 482, 585, low molecular weight heparins with antiXa Daunorubicin (Cerubidine, DaunoXome). See 591. 685, 689, 782. 1070, 1168 activity in, monitoring, 202 also PVDA (prednisone, vincristine, Clopidogrel (Plavix pharmacotherapy for alcohol withdrawal daunorubicin, and asparaginase) regimen adverse events with, 318 in, 420 exposure to, potential complications of, for and ticlopidine, cross-sensitivity between, rixivan. See Indinavir caregivers, 1099 802 ubicin. See Daptomycin DaunoXome. See Daunorubicin Clozapine (Clozaril), 68, 69, 161, 261, 370, upric chloride, warning related to, 973 DEA registration, of physicians, 78 785, 871 urrent FDA-Related Drug Information Deep vein thrombosis throinboembolism with, 730 agents pending FDA approval, 66, 162, with intravenous immunoglobulin, 532 lozaril. See Clozapine 262, 371, 480, 585, 685, 782, 869, 965, with thalidomide, 117 ognex. See Tacrine 1070, 1168 Delavirdine (Rescriptor), standardized order ombivir. See Zidovudine + lamivudine “Dear Health Professional Letters” related form for, 1187 ommit. See Nicotine to safety, 74, 168, 269, 381, 489, 595, Delayed puberty, in males, letrozole for, 222 ompounding issues, 804 693, 788, 874,, 794,7 1,1 681,0 7286,9 , 1137841 , 489, Demerol. See Meperidine LRRRoAaAmbPp bu rteevriiazteido ns Praensdcr isbeyrm boOlrsd eri n, En1t7r3y 5, 693, 788), 874, 971, 1078, 1174 DDeeppaakkoetnee.. SSeeee VVaallpprrooiicc aacciidd 1 alMloewr gy documawew ntatit on, > 234 86 new dosage forms/strengths, 64, 161, 261, Depakote ER. See Divalproex sodium; > procedures for, 608, 694 370, 479, 584, 684, 781, 866, 962, Valproic acid 1069, 1167 Depo yt. See ¢ ytarabine enhancement requests, Management OF, new drugs approved, 61, 158, 257, 367, DepoMorphine. See Morphine 69 474, 582, 681, 777, 862, 958, 1066, Dextroamphetamine and amphetamine medication error reduction, as 1163 (Adderall XR), 166, 266, 379, 482, 591, and medication request notification, 278 new indications approved, 64, 161, 261, 689, 786, 72. 9658, 1074, 1168 neonatal intensive care unit pathway for, 370, 479, 584, 684, 781, 866, 964, Diabetic neuropathy, gabapentin for, 737 794 1069, 1167 Dial-a-Flow device, 604 and patient-controlled analgesia, 1 yclobenzaprine, pharmacokinetics of, 338 Diazepam, endotracheal administration of, pharmacist's role in, pediatric perspective yclophosphamide, vincristine, and pred- 284 on. 1086 nisone (CVP) regimen, for chronic lympho- Didanosine (Videx, Videx EC) pharmacy work plan for, 981 cytic leukemia and small lymphocytic lym- buffered powder, standardized order form student nurse security access, 86 phomas, 1126 for, 1187 support considerations, 276, 382 ~~ yclophosphamide (Cytoxan, Neosar), expo- dosage adjustment in kidney failure, 1187 toxicology screen for, 386 sure to, potential complications ot, for dosage regimens for, 1156 training process, 84, 175 caregivers, 1099 standardized order form for, 1187 Confidentiality, PDAs and, 388 yclosporine (Restasis), 158, 258, 368, 478 warning related to, 74 Continuing Education Case Study Quiz _ ymbalta. See Duloxetine Diltiazem, ointment, 802 on adalimumab, 578 ytarabine (ARA-C, Cytosar U, DepoCyt). Diovan. See Valsartan on adefovir dipivoxil, 153 See also Fludarabine, cytarabine, and fil- Diphtheria and tetanus toxoids and acellular on aprepitant, 772 grastim (FLAG) regimen; Mitoxantrone, pertussis adsorbed, hepatitis B (recombi- on aripiprazole, 255 etoposide, and cytarabine (MEC) regimen nant), and inactivated poliovirus vaccine on emtricitabine, 1151 exposure to, potential complications of, combined (Pediatrix), 158, 258, 368, 478 on ezetimibe, 365 for caregivers, 1099 Diquafosol, 1073, 1173 on gemifloxacin mesylate, 860 high-dose (HIDAC) Discharge medications, automatic therapeutic on icodextrin peritoneal dialysis solution, for consolidation or relapse therapy in interchange and, 942 1196 Volume 38, December 2003 Index to Volume 38 Disseminated intravascular coagulation, advances in (future directions for), $2 410 quinine-induced, 908 “Dear Health Professional Letters” related mentoring programs, 411 Divalproex sodium (Depakote ER), 161, 261, to, 74, 168, 269, 381, 489, 595, 693, self-study modules related to patient safety, 370, 1069, 1167 788, 874, 971, 1078, 1174 415 Docetaxel (Taxotere), 161, 261, 370 double-check procedures and, 606 Efalizumab (Raptiva), 166, 266, 379, 482, exposure to, potential complications of, improvements in, $2 591, 689, 787, 872, 967, 968, 1072, 1074, for caregivers, 1099 interpreter errors and, 412 1170, 1173 warning related to, 876 ISMP fellowship in, 313, 1140 Etavirenz (Sustiva), 70, 166, 266, 377 9, 448029 Documentation in pediatric emergency department, 426 591, 689, 787 , 872, 968, 1074, 1173 of clinical intervention by dispensing practitioner education about, 565 standardized order form for, 1187 pharmacists, 346, 1141 technology and, $2 Effexor. See Venlafaxine PDAs and, 497, 1047, 1180 videos, free on Internet, 313 Effexor XR. See Venlafaxine of drug sample use, 80 Drug samples, dispensing of, documentation Efudex. See 5-Fluorouracil of indication-for-use of medication, 605, for, 80 Elderly. See also Geriatric Therapeutics Lt 7, 1178, 1179 Drug shortages, 803 adverse drug events in, after hospital Dofetilide (Tikosyn), physician order protocol and CPOE, 610 discharge, 919 for, 659 management of, 748 adverse drug-related events in, in Donepezil (Aricept), 590, 688, 785, 871 DTIC-Dome. See Dacarbazine ambulatory setting, 416 Doxercalciferol (Hectorol), 66, 162, 262, Duagen. See Dutasteride hypertension in, assessment and treatment, 371, 480, 585, 685, 782, 869, 965, 1070, Duloxetine (Cymbalta), 66, 162, 262, 371, INC 7 report, 920 1168 480, 585, 685, 782, 869, 965, 1070, 1168 low molecular weight heparin with antiXa Doxil. See Doxorubicin Duragesic. See Fentanyl, transdermal activity in, 207 Doxorubicin (Adriamycin, Rubex, Doxil), Dutasteride (Avodart, Duagen), 62, 159, 258 opioid-related psychotic behavior in, 529 exposure to, potential complications of, for Electrolytes, concentrated, 1176 caregivers, 1099 E automated dispensing machines and, 17 Drixoral Allergy Sinus Extended Release. See Ebastine, 69 dispensing of, 171 Acetaminophen, dexbrompheniramine Ebixa. See Memantine storage of, 603, 604, 880, 980 maleate, and pseudoephedrine sulfate Economics Eletriptan (Relpax), 159, 258, 368, 478 extended-release tablet of bar code medication administration, Eligard. See Leuprolide Drixoral Cold & Flu Extended Release. See 31%, S31 Elitek. See Rasburicase Acetaminophen, dexbrompheniramine of half tablets, 930 Ellence. See Epirubicin maleate, and pseudoephedrine sulfate of low-molecular-weight heparin in total Eloxatin. See Oxaliplatin extended-release tablet knee replacement, 833 Elspar. See Asparaginase Droperidol (Inapsine), 1171 of pharmacy-administered IV to oral Emasam. See Selegiline Drotrecogin alfa (Xigris), in sepsis manage- therapeutic interchange program, 444 Emcyt. See Estramustine ment, 1030 of tablet splitting education program, 453 Emend. See Aprepitant Droxia. See Hydroxyurea Editorials. See also Viewpoints EMSAM. See Selegiline Drug abuse, potential for, with carisoprodol, Building a Safety Net for Medication Use: Emtricitabine (Coviracil, Emtriva), 7 0, 166, 43 Challenges and Opportunities, $2 266, 379, 485. 591. 689. 787. 862 opR OR, Drug approval, FDA process for, changes in, Counterfeit Drugs: A Growing Concern, 1068, 1164 902 724 dosage regimens for, 1156 Drug concentrations, standardized, 171 The Devil Knows Latin, 626 dose adjustment in renal failure, 1156 Drug counterfeiting, 194, 724 The Drug Approval Process: Are Changes review Of, 1151 Drug delivery Coming?, 902 Emtriva. See Emtricitabine pneumatic tube systems for, 287 Geriatric Therapeutics: A New Hospital Enablex. See Darifenacin Druvgol udnitseceornst ifnoura, ti7o8n , unintended, 727 In MPehamromraicaym : FeLatouur e,L as3a1g0n a, 1118 EE nndbroetlr.a csheeea lE taandemricneipstt ration of drugs, 284 Drug-—drug interaction screening programs Management/Administrative Residencies: Enfurvirtide (Fuzeon), 70, 166, 266, 379, free online, assessment of, 662 Training Pharmacy Leaders of Tomor- 474, 583, 682. 778 proprietary, assessment of, 662 row, 410 Enjuvia. See Estr ens, conjugated Drug information Medication Counterfeiting: The Next Form Enoxacin Penetrex , in total knee replace- on Internet, evaluation of, 662 of Terrorism or Just Greed?, 194 ment, costs and outcomes with, 833 PDAs and, 498 Mentoring: From Student to Resident, 411 Enteral feeding, insulin and, 1004 Drug name suffixes, confusion about, 1121 New Directions in Outpatient Prescribing, Enteral feeding products Drug Reviews from The Formulary 106 and fluoroquinolone absorption, 508 (Continuing Education Series) Pharmacogenomics and Drug Product intravenous administration of, 525 adalimumab, 568 Labeling, 524 sphedra, 1094 adefovir dipivoxil, 144 From Printed Formularies to Online pn| edr] ine, and | epin1 epnrhirinnee, aprepitant, 763 Formularies, 1003 pinephrine, and ephedrine, mix-ups of, 629 aripiprazole, 247 Reducing Medication Errors with -pirubicin (Ellence emtricitabine, II] Prescription Bar Coding, 10 exposure to, potential complications of, for ezetimibe, 357 Summit Meeting on Pharmaceutical Bar caregivers, 1099 gemifloxacin mesylate, 851 Coding, 817 warning related to, 973 icodextrin peritoneal dialysis solution, 669 Education and training. See also Patient edu- Epivir. See Lamivudine influenza virus vaccine (live, intranasal), cation Eplerenone (Inspra), 62, 159, 1167 947 about phytonadione, 458 Epoetin alfa. See also Erythropoietin omalizumab, 1052 about safer medication use, 565 for anemia in critical illness, 1009 rasburicase, 50 ISMP fellowship in medication safety, 313, e-prescribing, 106 teriparatide, 463 1140 Erbitux. See Cetuximab Drug safety. See also Medication errors management/administrative residencies, Ergotamine tartrate and caffeine (Cafergot), Phart 1197 Hospital Pharmacy Index to Volume 38 warning related to, 74 Famotidine (Pepcid AC-Maximum Strength), Fortigel. See Testosterone gel in Ergot toxicity, with OTC drug, 200 1167 Fosamprenavir, 873, 968, 1075, 1173 Erythropoietin. See also Epoetin alfa Feldene. See Piroxicam Fosrenol. See Lanthanum carbonate we for anemia, 291 Femring. See Estradiol vaginal ring Foznol. See Lanthanum carbonate Escitalopram oxalate (Lexapro), 62, 161, Fentanyl, transdermal (Duragesic), abuse of, Fuzeon. See Enfurvirtide I lep: 261, 370, 688, 787, 872, 968, 1074, 1173 1S Hep Esomeprazole (Nexium), 1073, 1173 Ferric ({II) hexacyanoferrate(II) (Radiogar- G Hep Estorra. See Eszopiclone dase), 1171 Gabapentin (Neurontin) ac Estrace VR. See Estradiol Fexofenadine (Allegra-D), warning related to, for diabetic neuropathy, 737 ch Estradiol (Alora, Estrace, Estrace VR, 489 high-dose, abrupt withdrawal of, status Menostar, Vivelle-Dot), 70, 166, 379, 485, Filgrastim. See also Fludarabine, cytarabine, epilepticus after, 200 I lep 591, 689, 787, 872, 968, 1074, 1171, and filgrastim (FLAG) regimen for hyperhidrosis, 25 Hep 1173. See also 17-Beta-estradiol Finacea. See Azelaic acid Gabitril. See Tiagibine o} Estradiol vaginal ring (Femring), 474, 583, FlexPen. See Protamine/insulin aspart Galantamine (Reminyl), 376, 485, 591, 689, 682, 278 Flucytosine (Ancobon), warning related to, 787, 873, 968, 1075, 1173 Estramustine (Emcyt), exposure to, potential 973 Gamma-hexachlorocyclohexane (Lindane), complications of, for caregivers, 1099 Fludara. See Fludarabine warning related to, 595 Estrasorb. See 17-Beta-estradiol Fludarabine, cytarabine, and filgrastim Gamunex. See Immune globulin intravenous Estr« gens (FLAG) regimen, for induction therapy of (human) conjugated (Enjuvia), 70, 166, 265, 376, acute myelogenous leukemia or myelodys- Gastritis, hemorrhagic, topical isopropyl 482, 591, 689, 786, 872, 968, 1074, plastic syndrome, 320 alcohol and, 17 1173 Fludarabine (Fludara), exposure to, potential Gastroesophageal reflux, in children, 212 conjugated (Premarin), warning related to, complications of, for caregivers, 1099 Gatifloxacin (Tequin, Zymar), 582, 682, 778 269 FluMist Vaccine. See Influenza vaccine warning related to, 270 conjugated/medroxyprogesterone acetate Flunisolide (Aerospan), 66, 162, 262, 371, Gefitinib (Iressa), 68, 164, 264, 372, 481, (Prempro, Premphase), 479, 584, 684, 480, 585, 685, 782, 869, 965, 1070, 1168 589, 681, 778, 865, 961 781, 866, 962 Fluoroplex. See 5-Fluorouracil review of, 734 warning related to, 269 Fluoroquinolone absorption interactions, Gemcitabine (Gemzar) Eszopiclone (Estorra), 376, 485, 590, 689, 292, 506 exposure to, potential complications of, for 787, 872, 968, 1074, 1173 5-Fluorouracil (Adrucil, Carac, Efudex, Fluo- caregivers, 1100 Etanercept (Enbrel), 265, 379, 485, 591, 689, roplex), exposure to, potential complica- warning related to, 876 785, 787, 870, 871, 964, 1069, 1070, tions of, for caregivers, 1100 Gemfibrozil (Lopid), warning related to, 876 1167 Fluoxetine (Prozac), 261, 370, 479 Gemifloxacin mesylate (Factive), 376, 481, Ethambutol (Myambutol), warning related Flutamide, pneumonitis with, 1006 589, 686, 781, 1170 to, 87 S Fluticasone/salmeterol (Advair), 162, 262, review of, 851 Ethinyl estradiol/levonorgestrel (Seasonale), 371, 685, 782, 869, 965, 1070, 1168 Gemzar. See Gemcitabine 785. 873. 968 warning related to, 976 Generic drugs, in managed care, 1079 Ethyol. See Amifostine Fluvastatin (Lescol, Lescol XL), 70, 167, 266, Genotropin. See Somatropin [rDNA origin] Etopophos. See Etoposide 379, 485, 591, 689, 781, 787, 866 Geodon. See Ziprasidone Etoposide (Toposar, VePesid, Etopophos). See Folex PFS. See Methotrexate Geriatric Therapeutics, 310. See also Elderly also Bleomycin, etoposide, and cisplatin Folinic acid. See Leucovorin calcium adverse events after hospital discharge, 919 (BEP) regimen; Mitoxantrone, etoposide, Fondaparinux sodium (Arixtra), 781, 866, drug dosage and administration in, “start and cytarabine (MEC) regimen 964 low and go slow” adage for, 634 exposure to, potential complications of, for Food and Drug Administration (FDA) hypertension assessment and treatment, caregivers, 1099 drug approval process of, changes in, 902 JNC 7 report, 920 Etoposide and cisplatin (EP) regimen, for tes- proposed bar coding rule, 10, $7, $11 Gleevec. See Imatinib mesylate ticular cancer, 921 Foradil. See Formoterol fumerate Gliadel. See Carmustine Etoricoxib (Arcoxia), 70, 166, 379, 485, 591, Formoterol fumerate (Foradil), unit-dose cap- Glucophage XR. See Metformin 689, 787, 873, 968, 1074, 1173 sules for inhalation, 904 GoLYTELY. See PEG-3350 and electrolytes Everolimus (Certican), 785, 873, 968, 1075, Formulary Granisetron (Kytril), 161, 261, 370 1173 annual review of, 1175 Excedrin Migraine. See Acetaminophen, dosage forms listed in, 1176 H aspirin, caffeine drugs properly listed in, 1175 Haemophilus b conjugate vaccine, and Extended-release formulations, drug name one-time orders for drugs not in, 1175 influenza vaccine, confusion of, 110 suffixes for, 1121 from printed to online, 1003 Head lice, pediculicide resistance in, 241 Extina. See Ketoconazole foam The Formulary Information Exchange Hectorol. See Doxercalciferol Extraneal. See Icodextrin adverse event reference, 801 Helicide. See Bismuth subcitrate, metronida- Ezetimibe (Zetia), 62, 159, 260 anergy skin texting, 802 zole, tetracycline and lisinopril (Zestril), confusion of, 526 cisplatin/epinephrine in bovine collagen gel, Hemodialysis review of, 357 801 catheter patency in, low molecular weight warning related to, 876 cross-sensitivity of clopidogrel and heparin with antiXa activity for, 208 ticlopidine, 802 orders, pharmacist review of, 79 Fr diltiazem ointment, 802 sodium chloride for, 604, 880 Fabrazyme. See Agalsidase beta endotracheal drug administration, 284 Hemolytic anemia, levofloxacin-induced, Fac5ia3l2 hyperpigmentation, with imipramine, low-dose oral vitamin K, 284 1007 neonatal abstinence syndrome, 282 Heparin Factive. See Gemifloxacin mesylate vesicant policies, 282 low-molecular-weight Fall(s) Forsamprenavir, 786 with antiXa activity, monitoring, 202 prevention of, 390 Forteo. See Teriparatide retroperitoneal hematoma caused by, 729 risk assessment for, 390 Fortical. See Calcitonin therapeutic interchange of, 652 1198 Volume 38, December 2003 index to Volume 38 in total knee replacement, costs and Idarubicin (Idamycin), exposure to, potential Intravenous (IV) drugs outcomes with, 833 complications of, for caregivers, 1100 administration of weight-based protocol for, patient weight Ifex. See Ifosfamide second check of, nurses for, 606 tor, 198 Ifosfamide (Ifex), exposure to, potential com- via intra-arterial lines, 415 Hepatic artery infusion, 392 plications of, for caregivers, 1100 standardized concentrations for, 980 Hepatitis, with celecoxib, 117 Imatinib mesylate (Gleevec), 161, 167 261 Intravenous immunoglobulin(s) (VIG), Hepatitis B 266, 370, 689, 781, 866 thrombotic complications with, 532 adefovir dipivoxil for, 144 Imavist. See AFO150 Intravenous (IV) to oral therapeutic inter- chronic, emtricitabine for, 1155 Imipenem-cilastatin sodium, in AutoDose change program, pharmacy-administered, vaccine, chronic ADRs with, 11 Infusion System bags, stability of, 130 444 Hepatitis C, 180 Imipramine, facial hyperpigmentation with, Investigational drugs Hepatotoxicity 732 expiration dates for, 881 of angiotensin II receptor blockers, 417 Imiquimod (Aldara), 787, 873, 970, 1075, physician research on, pharmacist support of candesartan, 417 1E73 for, 140 of montelukast, 530 warning related to, 74 Investigational drug service pharmacist, 140 of propylthiouracil, 319 Immune globulin (human) (Carimune NF), lodine-131 tositumomab (Bexxar), 68 of valsartan, 417 479, 584, 684 Ipecac syrup (Syrup of Ipecac), 590, 688, Hepsera. See Adefovir dipivoxil Immune globulin intravenous (human) 785, 871 Herbal medicine, use of, in medication (Gamunex), 1066, 1164 Irbesartan (Avapro), 65 history, 601 Immunization, of HIV-infected (AIDS) Iressa. See Gefitinib Hexalen. See Altretamine patients, tracking, with computerized Irinotecan (Camptosar), exposure to, poten High-alert medications reminder system, 758 tial complications of, for caregivers, 1100 safety of, 171 Inapsine. See Droperidol Iron dextran, intravenous infusion, dosage, standardized concentrations for, 171 Indinavir (Crixivan) calculation of, 820 Highly active antiretroviral therapy (HAART) dosage adjustment in liver failure, 1187 Iron sucrose injection (Venofer) , Warning dose reductions in end organ disease, 1187 standardized order form for, 1187 related to, 1174 standardized order form for, 1187 Indinavir/ritonavir, standardized order form Iron supplements, and fluoroquinolone Hivid. See Zalcitabine for, 1187 absorption, 508 HIV-infected (AIDS) patients Infliximab (Remicade), 584, 684, 782 ISMP Adverse Drug Reactions antiretroviral therapy for tuberculosis exacerbation with, 113 ADR-related reports from Archives of dose reductions in end organ disease, 1187 Influenza vaccine (FluMist Vaccine), 69, 164, Interna! Medicine, 633 standardized order form for, 1187 264, 372, 481, 589, 686, 777, 865, 961, adverse drug events with COX-2 emtricitabine for, 1152 1068 inhibitors, 1122 vaccination rates among, tracking, with review of, 947 adverse drug reactions in ambulatory computerized reminder system, 758 Informed consent, for drug therapy, 80 setting, 416 Hoelzer regimen, for adult acute lymphob Infusion pump, 604 adverse drug reactions outside hospital, as- tic leukemia, 436 alarms for, 882 317 Homeopathy, use of, in medication history, free-flow protection with, 980 adverse effects of clopidogrel, 318 601 InnoPran XL. See Propranolol hydrochloride adverse reactions to food ingredient, 1007 Human immunodeficiency virus (HIV). See Inspra. See Eplerenone adverse reactions to Quorn, 1007 HIV-infected (AIDS) patients Institute for Safe Medication Practices. See amoxicillin crystalluria and acute renal Humatrope. See Somatropin also ISMP Adverse Drug Reactions; ISMP failure, 732 Humira. See Adalimumab Medication Error Report Analysis anemia with proton-pump inhibitor, 112 Hyaluronidase (Vitrase), 165, 376, 485, 585, fellowship in medication safety, 313, chronic adverse drug reactions with 689, 784, 870, 968, 1075, 1173 1140 hepatitis B vaccination, 117 Hycamtin. See Topotecan Insulin drug-induced thrombocytopenia, 418 Hydrea. See Hydroxyurea combination products, and errors, 110 ergot toxicity with OTC drug use, 200 Hydroxyurea (Droxia, Hydrea) and enteral feeding, 1004 facial hyperpigmentation with imipramine, acute tumor lysis syndrome with, 632 as floor stock, 81 => 3? exposure to, potential complications of, for sliding-scale order for, on MAR, 881 fatal lactic acidosis with metformin and caregivers, 1100 Insulin aspart (NovoLog), 64 antiretrovirals, 909 Hypercalcemia of malignancy, prevention of, warning related to, 596 hepatic failure due to propylthiouracil, 319 zoledronic acid vs pamidronate for, 1148 Insulin detemir, 166, 266, 379, 485, 591, hepatitis with celecoxib, 117 Hypercholesterolemia, ezetimibe for, 357 689, 787, 873, 970, 1075, 1168 hepatotoxicity of angiotensin II receptor Hyperglycemia, in critically ill patients, man- Insulin glargine (Lantus), 684, 781, 866 blockers, 417 agement of, 702 proper use of, 526 montelukast-induced, 530 Hyperhidrosis, gabapentin for, 25 Insulin glulisine, 871, 970, 1075, 1173 hypersensitivity pneumonitis with Hyperprolactinemia, risperidone-induced, Insulin syringe, and tuberculin syringe, confu- anagrelide, 1007 270 sion of, 15 immediate hypersensitivity to clavulanic Hypderrutge ntshieorna py for, ALLHAT findings and, IInntteerrffeerroonn -baelftaa,- lpas yc(hAovsoinse x)w,i th,3 704,1 74 9, 584, intearcfiedr, on 11a2l4f a and psychosis, 417 533 684, 781, 866 levofloxacin and Achilles tendon rupture, management of warning related to, 489 L008 in elderly, JNC 7 guidelines for, 920 Interferon-beta-1b (Betaseron), 479, 584, levofloxacin-induced hemolytic anemia, JNC 7 guidelines for, 913 684, 1167 1007 Internet mefloquine-related psychiatric events, 18 1 drug information on, evaluation of, 662 multiorgan failure due to “statin,” 17 Icodextrin (Extraneal), 68, 164, 264, 481, use in pharmacy, 501 neuroleptic malignant syndrome and 589, 686, 784, 870, 966, 1170 Intra-arterial lines, [V medication administra- olanzapine, 530 review of, 669 tion via, 415 neurologic disorders with MMR vaccine, Idamycin. See Idarubicin IntraDose. See Cisplatin/epinephrine 128 1199 Hospital Pharmacy Index to Volume 38 neutropenia due to valproic acid, 730 Duragesic patch abuse, 15 and brand/generic drug names, 1179 opioid-associated psychotic behavior in enteral feeding solution administered and Broselow system, 1177 Lar elderly, 529, 746 intravenously, 525 and compliance assessment, 11 Lar panhypogammaglobulinemia with ephedrine-epinephrine mix-ups, 629 and concentrated electrolytes, 1176 Lat phenytoin, 199 errors of precision, 712 and control or distribution of products, pneumonitis with antiandrogens, 1006 fellowship in medication safety, 313, 1176 Las prevention of ADEs with rounding 1140 definition of “readily accessible” Lat pharmacists, 1122 Haemophilus b conjugate vaccine and information, 1175 priapism with antipsychotic therapy, 319, influenza vaccine, confusion of, 110 definition of “secure,” 1176 418 insulin and total parenteral nutrition, 1004 and documentation of indication-for-use of LD psoriasis flare-ups with serotonin reuptake insulin combination products and errors, medication, 1177, 1178, 1179 Le: inhibitor, 113 110 documentation requirements, 1175 psoriasis with rofecoxib, 1124 intra-arterial lines and intravenous and dosage forms listed in formulary, Le! psychiatric adverse events with medications, 415 1176 levetiracetam, 1007 intrathecal vincristine, fatal error with, and drugs properly listed in formulary, quinine-induced disseminated intravascular 313 1175 coagulation, 908 iron dextran dosing by lean body weight and inventory of controlled substances, red blood cell aplasia with mycophenolate versus actual body weight, 820 1177 mofetil, 910 Lantus insulin use, 526 and one-time orders for drugs not in retroperitoneal hematoma due to LMW leucovorin calcium (folinic acid) and folic formulary, 1175 heparin, 729 acid, confusion of, 1121 and orders for compounded drugs, 1179 retroperitoneal hemorrhage due to levothyroxine doses, 196 and orders to resume home medications, warfarin, 730 look-alike names and packages, and 1179 ribavirin therapy for SARS and adverse stocking errors in automated dispensing and pediatric code carts, 11 events, 1124 cabinets, 312 and PRN orders, 1179 risperidone-induced hyperprolactinemia, medication safety videos, free via Internet, and sodium bicarbonate of different 270 313 strengths, 1177 shock-like sensations with antidepressant metric weight for liquid doses, 14 and storage of medications, 1176 withdrawal, 631 multiple errors, 526 and tapering orders, 1179 sildenafil-related seizures, 18 nurse computer order entry leading to and titrating orders, 1179 sleepwalking caused by selective serotonin error, 630 and unit inspections, 1177 reuptake inhibitor, 633 patch versus oral therapy with clonidine, and weight-based dosing for pediatrics, status epilepticus after gabapentin 728 1179 withdrawal, 200 patient data monitoring and prevention of Journal clubs, 709 steroid-induced myopathy, 16 adverse events, 818 systemic absorption of ophthalmic propylthiouracil—Purinethiol mix-ups, 905 K medication and overdose in child, 201 self-study modules on patient safety issues, Kaletra. See Lopinavir/ritonavir tenofovir and creatine kinase elevation, 18 415 Keppra. See Levetiracetam thalidomide-induced bradycardia, 910 Synagis (palivizumab) reconstitution, Ketek. See Telithromycin thalidomide-induced neuropathy, 200 precautions with, 312 Ketoconazole foam (Extina), 871, 970, 1075, thalidomide-related deep vein thrombosis tracking orders during clarification, 1120 1173 and pulmonary embolism, 117 translation errors with clinical a Kidney disease. See also Renal failure thrombocytopenia, with vancomycin, consequences, 412 low molecular weight heparin with antiXa 1122 tuberculin syringe confused with insulin activity and, 207 thrombotic complications of IV syringe, 15 Kytril. See Granisetron pom immunoglobulin therapy, 532 unintended discontinuation of drugs, 727 tooth discoloration with linezolid, 633 unit-dose capsules for inhalation, 904 L topical isopropyl! alcohol and hemorrhagic vaccines and neuromuscular blockers, Labeling gastritis, 17 mix-ups between, 109 of anesthesia medications, 605 tuberculosis exacerbation with infliximab, vancomycin administration route for brand/generic drug, 603 113 systemic infection, 728 patient identifiers on, 170, 881 tumor lysis syndrome caused by varicella virus vaccine and varicella-zoster pharmacogenomics and, 524 hydroxyurea, 632 immune globulin, confusion of, 198 Lactic acidosis, fatal, with metformin plus valsartan-induced angioedema, 909 weight-based protocols, weighing patients antiretrovirals, 909 visual hallucinations for, 198 Lamictal. See Lamotrigine zolpidem-induced, 632 Zetia (ezetimibe)—Zestril (lisinopril) Lamivudine (Epivir). See also Zidovudine, with zonisamide, 530 mix-up, 526 lamivudine, abacavir; Zidovudine plus ISMP Medication Error Report Analysis Isopropyl alcohol, topical, and hemorrhagic lamivudine abbreviation for intranasal, 1004 gastritis, 17 dosage adjustment in kidney failure, 1187 CDC-recommended vaccine abbreviations, Istalol. See Timolol dosage regimens for, 1156 726 standardized order form for, 1187 chemotherapy safety standards, 1029 Lamotrigine (Lamictal), 167, 261, 266, 370, clinical decision-support systems and Job satisfaction, among hospital pharmacists, 379, 479, 485, 591, 689, 781, 866, 964 adverse events, 818 factors affecting, 1037 Lansoprazole (Prevacid) color-coding of 25 gauge safety needles, Joint Commission on Accreditation of alternate day dosing of, 926 415 Healthcare Organizations (JCAHO). See in intravenous to enteral PPI conversion color-coding of ophthalmologic also National Patient Safety Goals (NPSG) program, 753 medications, 905 medication management standards for warning related to, 596 drug name suffixes, confusion about, 20802, 8482,, 11 75 Lanthanum carbonate (Fosrenol, Foznol), 1121 and annual review of formulary, 1175 166 7, 266, 379, 480, 585, 685, 782, 869, 1200 Volume 38, December 2003 _ Index to Volume 38 965, 1072, 1168 1174 look-alike names and packages and, 312, Lantus. See Insulin glargine tooth discoloration with, 633 629 Lariam. See Mefloquine warning related to, 596, 974 of omission, 1120 Laronidase (Aldurazyme), 69, 165, 167, 266, Lioresal. See Baclofen in pediatric emergency department, 426 379, 485, 681, 778, 865, 961 Lipitor. See Atorvastatin prevention of with standardized HIV Lasagna, Lou (in memoriam), 1118 Liquid doses, metric weight and, 14 antiretroviral order form, 1187 Latanoprost/timolol (Xalcom), 66, 162, 262, Lisinopril (Prinivil, Zestril) reduction of, bar code medication adminis- 371, 480, 585, 685, 782, 869, 965, 1072, and ezetimibe (Zetia), confusion of, 526 tration and, 10, $5, $22 1168 warning related to, 1078 in transcription, 630, 728 LDP-341. See Bortezomib Lisinopril/hydrochlorothiazide (Zestoretic), translator/interpreter errors and, 412 Lean body weight, versus actual body weight, warning related to, 974 Medication history, OTC drugs, herbals, and in dosage calculation, 820 Liver failure homeopathies in, 601 Leflunomide (Arava), 165, 265, 376, 481, dosage adjustment in, for HIV Medication Use Evaluation (MUE), of 589, 686, 781, 866, 964 antiretroviral therapy, 1187 meperidine, 30 Lepirudin (Refludan), warning related to, 973 with propylthiouracil, 319 Mefloquine (Lariam) Lercanidipine (Zanidip), 66, 162, 262, 371, Lomustine (CeeNU), exposure to, potential psychiatric events related to, 18 480, 585, 685, 782, 869, 965, 1072, 1168 complications of, for caregivers, 1100 warning related to, 18, 1174 Lescol. See Fluvastatin Lopid. See Gemfibrozil Melphalan (Alkeran), exposure to, potential Lescol XL. See Fluvastatin Lopinavir/ritonavir (Kaletra), standardized complications of, for caregivers, 1100 Letrozole, for delayed puberty in males, 222 order form for, 1187 Memantine (Ebixa, Namenda), 72, 167, 268, Letters to the Editor, A standardized HIV Loratadine (Claritin), 64, 161, 262 380, 485, 592, 690, 787, 871, 873, 967, antiretroviral order form can help prevent Losartan (Cozaar), 65, 165, 264, 372, 481, 970, 1073, 1075, 1163 medication errors, 1187 589, 686, 870 Menostar. See Estradiol Leucovorin calcium, as folinic acid, confusion Lovastatin (Mevacor), warning related to, 74 Mentoring programs, 411 with folic acid, 1121 Lumenax. See Rifamixin; Rifaximin Meperidine (Demerol) Leukemia Lumiracoxib (Prexige), 786, 873, 970, 1075, academic detailing of, 30 acute lymphoblastic. See Acute 1168 warning related to, 876, 1078 lymphoblastic leukemia Lutropin alpha (Luveris), 1170 6-Mercaptopurine (Purinethol) acute myelogenous. See Acute myelogenous Luveris. See Lutropin alpha exposure to, potential complications of, leukemia Lymphoma, small lymphocytic, CVP for caregivers, 1100 chronic lymphocytic. See Chronic (cyclophosphamide, vincristine, and pred- and propylthiouracil, confusion of, 905 lymphocytic leukemia nisone) regimen for, 1126 Meropenem (Merrem IV), 72, 167, 268, 380, Leukeran. See Chlorambucil 485, 592. 690, 787, 873, 970, 1075, 1174 Leuprogel. See Leuprolide M Merrem IV. See Meropenem Leuprolide (Eligard, Leuprogel), 479, 584, Managed care, 710 Metaxalone, pharmacokinetics of, 338 684 Managed Care Pharmacist Metformin (Glucophage XR), 584, 684, 781 One-Month Leuprogel, 167, 266 and allocation of prescription drug plus antiretrovirals, fatal lactic acidosis Three-Month Depot, 167, 266, 379, 485, benefits, 271 caused by, 909 592, 690, 787, 873, 970, 1075, 1173 generic drug use, 1079 Methocarbamol, pharmacokinetics of, 338 Leustatin. See Cladribine lifestyle drugs and pharmacy benefit Methotrexate (Folex PFS, Mexate, Levaquin. See Levofloxacin coverage policies, 790 Rheumatrex), exposure to, potential com- Levetiracetam (Keppra), 866, 962, 1069 roles of, 271 plications of, for caregivers, 1100 psychiatric adverse events with, 1007 Manganese chloride injection, warning Methoxsalen (8-MOP, Oxsoralen-Ultra), warning related to, 1174 related to, 596 warning related to, 974 Levitra. See Vardenafil Manufacturers directory, 2003, 394 Methylaminolevulinate (Metvix), 967, 1073, Levodopa/carbidopa/entacapone, 72, 167, Matulane. See Procarbazine 1170 266, 379, 485. See also Carbidopa, lev- Maxipime. See Cefepime Methylphenidate (MethyPatch, Ritalin), 72, odopa, entacapone Measles, mumps, and rubella (MMR) 167, 268, 380, 485, 592, 688, 785, 870, Levofloxacin 1.5% (Quixin), 787, 873, 970 vaccine, neurologic disorders with, 128 966, 1073, 1170 1075, 1173 Mechlorethamine (Mustargen) MethyPatch. See Methylphenidate Levofloxacin (Levaquin), 72, 167, 266, 379, exposure to, potential complications of, Metoclopramide (Reglan), warning related to, 485, 781, 866 for caregivers, 1100 976 and Achilles tendon rupture, 1008 warning related to, 974 Metvix. See Methylaminolevulinate hemolytic anemia with, 1007 Medicaid, 509 Mevacor. See Lovastatin Levomethadyl acetate (Orlaam), warning Medication counterfeiting, 194, 724 Mexate. See Methotrexate related to, 1078 Medication errors. See also ISMP Medication Midamor. See Amiloride Levonorgestrel/ethinyl estradiol (Seasonale), Error Report Analysis Miglustat (Zavesca), 590, 690, 787, 873, 1066, 1164. See also Ethinyl estradiol/lev- abbreviations causing, 1 72, 173, 285, 565, 958, 1068, 1164 onorgestrel 626, 728 Milrinone (Primacor), warning related to, 977 Levothyroxine sodium (Synthroid), dosing, administration, reduction of, bar code decimal point placement in, 196 medication administration and, $5 Mirtazapine (Remeron), warning related to, Lexapro. See Escitalopram oxalate automated dispensing devices and, 312 5 Lidocaine, 72, 167, 266, 380, 485 cascade of, 526 MitoExtra. See Mitomycin Lifestyle drugs CPOE and, 227 Mitomycin (MitoExtra, Mitozytrex, definition of, 790 in chemotherapy, 712 Mutamycin), 64, 72, 161, 167, 261, 268, and pharmacy benefit coverage policies, dispensing, reduction of, bar code 380, 486, 592, 690, 787, 873, 970, 1075 790 medication administration and, S6 1174 uses of, 790 double-check procedures and, 606 exposure to, potential complications of, Lindane. See Gamma-hexachlorocyclohexane drug name similarity and, 526, 629 for caregivers, 1100 Linezolid (Zyvox), 72, 167, 268, 380, 485, Latin abbreviations and, 285, 626 Mitoxantrone (Novantrone) 592, 690, 787, 873, 964, 970, 1070, 1075, with liquid doses, metric weight and, 14 exposure to, potential complications of, for Hospital Pharmacy 1201 index to Volume 38 caregivers, 1100 Neuroleptic malignant syndrome, low-dose sy ndrome, 530 pr warning related to, 87 olanzapine and, 530 Olanzapine/fluoxetine (Symbyax), 786, 873, or Mitoxantrone, etoposide, and cytarabine Neurontin. See Gabapentin 970, 1076, 1174 Panc (MEC) regimen, for relapsed or refractory Neuropathy Olmesartan medoxomil/hydrochlorothiazide in acute myelogenous leukemia, 218 diabetic, gabapentin for, 737 (Benicar HCT), 72, 167, 268, 380, 486, Pan Mitozytrex. See Mitomycin thalidomide-induced, 200 592, 690, 781, 866, 962 pt MLN341. See Bortezomib Neutrexin. See Trimetrexate Olux. See Clobetasol propionate Pant Modafinil (Provigil), 871, 967, 1073 Neutropenia, caused by valproic acid, 730 Omalizumab (Xolair), 590, 686, 777, 865, in Moduretic. See Amiloride/hydro- Nevirapine (Viramune), standardized order 961, 1052, 1068 chlorothiazide form for, 1187 review of, 1052 WwW Monitoring, of effects of first dose of new Nexium. See Esomeprazole Omapatrilat (Vanlev), 68, 164, 690, 788, Para drug, 605 Niacin (Niaspan), 72, 167, 268, 380, 486, 874, 970, 1076, 1174 Parc Montelukast (Singulair), 261, 370, 479 592, 690, 788, 873, 970, 1076, 1174 Omeprazole (Prilosec), 68, 164, 264, 372, hepatotoxicity of, 530 Niaspan. See Niacin 481, 589, 686 8-MOP. See Methoxsalen Nicotine (Commit), 61, 160, 260 anemia with, 112 Morphine (DepoMorphine), 967, 1075, 1174 Nilutamide, pneumonitis with, 1006 warning related to, 596 Moxifloxacin (Avelox, Avelox IV, Vigamox), Nipent. See Pentostatin Omeprazole magnesium (Prilosec OTC), 7 72, 479, 582, 584, 682, 684, 778, 865 Nitazoxamide (Alinia), 61, 160, 260, 368 86 5, 961, 1068 warning related to, 877 Nonnucleoside reverse transcriptase inhibitors Oncaspar. See Pegaspargase MT 300, 166, 268, 380, 486, 592, 690, 788, dose reductions in end organ disease, 1187 Oncovin. See Vincristine 873, 970, 1076, 1170 standardized order form for, 1187 Online analytical processing, in data mining, Multiorgan failure, atorvastatin-related, 17 Norvir. See Ritonavir 845 Mustargen. See Mechlorethamine Novantrone. See Mitoxantrone Online formulary, 1003 Mutamycin. See Mitomycin NovoLog. See Insulin aspart Ophthalmic drugs Myambutol. See Ethambutol Nubain. See Nalbuphine color-coding of, 905 Mycophenolate mofetil (CellCept), red blood Nucleoside reverse transcriptase inhibitors as floor stock, 80 cell aplasia with, 910 dosage regimens for, 1156 systemic absorption of, and overdose in Myelodysplastic syndrome, fludarabine, dose reductions in end organ disease, 1187 child, 201 wre cytarabine, and filgrastim (FLAG) regimen standardized order form for, 1187 Opiates, psychiatric symptoms with, 746 for, 320 Nucleotide reverse transcriptase inhibitors Opioids, psychotic behavior caused by, in Myleran. See Busulfan dose reductions in end organ disease, 1187 elderly, 529 Myopathy, steroid-induced, 16 standardized order form for, 1187 Orap. See Pimozide Nurse(s) Orders N identification of patient's own medications, clarification of, and errors of omission, Nalbuphine (Nubain), warning related to, 81 1120 976 removal of medications from Automated oral/telephone, read-back of, 978 Namenda. See Memantine Medstations, 604 Orlaam. See Levomethadyl acetate Naropin. See Ropivacaine and second check of intravenous drug Orphenadrine, pharmacokinetics of, 338 Nateglinide (Starlix), 166, 268, 380, 486, administration, 606 Osteogenesis imperfecta, 181 592, 690, 788, 873, 970, 1076, 1174 Nursing, and bar code medication adminis- Osteoporosis warning related to, 489 tration, $14, $16, $22, $30 in men, pharmacotherapy for, 466 National Patient Safety Goals (NPSG) Nutritional support, for cancer cachexia, 389 postmenopausal for 2003, compared with NPSG for 2004, Nutritional Support ¢ onsultant, mandgement pharmacotherapy for, 464 980 of hyperglycemia in critically ill patients, zoledronic acid for, 828 adherence to, 604 702 Outpatient prescribing alternative approaches to, requesting advances in (tuture directions for), 106 review of, 494 0 e-prescribing for, 106 compliance with Obesity, low molecular weight heparin with technology and, 106 recommendations for, 490 antiXa activity and, 210 Over-the-counter drugs survey of, 174, 496 Off-Label Drug Uses ergot toxicity with, 200 FAQs, Web site for, 174 acetylcysteine for prevention of contrast use of, in medication history, 601 medication-related, 170 media nephropathy, 122 Ovidrel. See Choriogonadotropin alfa implications for pharmacy, 496 alteplase for pleural effusion Oxaliplatin (Eloxatin), 64 requirements of, 977 (parapneumonic), 1024 Oxcarbazepine (Trileptal), 964, 1070, 1167 Sentinel Event Alert Advisory Group and, baclofen for alcohol withdrawal, 552 Oxsoralen-Ultra. See Methoxsalen 490 Oxybutynin (Oxytrol), 68, 72, 164, 167, Navane. See Thiothixene gabapentin for hyperhidrosis, 25 268, 380, 486, 583, 682 P Navelbine. See Vinorelbine lansoprazole, alternate day dosing, 926 Oxytrol. See Oxybutynin P Needles, 25 gauge safety, color codes for, 415 letrozole for delayed puberty in males, 222 Nefazodone (Serzone), warning related to, sildenafil for pulmonary hypertension P P 381 (pediatric, neonatal), 646 Paclitaxel (Taxol), exposure to, potential P Nelfinavir mesylate (Viracept), 684, 781 topiramate for binge eating disorder, 1133 complications of, for caregivers, 1100 standardized order form for, 1187 topiramate for weight loss with Pain management warning related to, 596 antipsychotic-induced weight gain, 328 advances in (future directions for), 30 Neonatal abstinence syndrome, treatment of, zoledronic acid for postmenopausal meperidine for, academic detailing of, 30 282 osteoporosis, 828 Palivizumab (Synagis) Neonatal intensive care unit pathway, for OGT 918 (Vevesca), 68, 164 reconstitution, precautions with, 312 computerized prescriber order entry, 794 Olanzapine (Zyprexa), 68, 164, 264, 372, warning related to, 168 Neosar. See Cyclophosphamide 481, 589, 686, 784, 866, 870, 964, 966, Palonosetron (Aloxi), 786, 874, 961, 970, Nephropathy, contrast media, prevention of, 1070, 1072, 1170 1068, 1164 acetylcysteine for, 122 low-dose, and neuroleptic malignant Pamidronate disodium (Aredia), for 1202 Volume 38, December 2003